News
New Healthcare Partnership: AnsibleHealth and Fullpower-AI
AnsibleHealth, a pioneering virtual pulmonary practice, is proud to collaborate with Fullpower-AI, the frontrunner in AIoT contactless biosensing technology. This partnership aims to elevate patient care by seamlessly integrating state-of-the-art passive sensing technologies with a best-in-class clinical care model, ultimately significantly improving patient experience and health outcomes.
Ming Jack Po, MD, Ph.D., CEO and Founder of AnsibleHealth: “Fullpower’s demonstrated expertise and impressive track record in AIoT contactless biosensing are unlocking unprecedented opportunities for us to proactively care for our patients in ways that were simply not possible before. We are incredibly excited to collaborate with Philippe and his team to integrate AI-driven biosensing into actual patient care, transforming the clinical paradigm from reactive to proactive care. “
Philippe Kahn, CEO of Fullpower-AI: “AnsibleHealth’s achievements are nothing short of extraordinary. Dr. Ming Jack Po and his team commitment to patient care resonates deeply with our vision at Fullpower-AI. This partnership marks a significant step forward in our journey to transform healthcare with cutting-edge Generative AI solutions.”
About Fullpower-AI®
Fullpower-AI® delivers the KOA platform, an enterprise-grade LAM (Large Action Model) biosensing solution engineered to scale specialised conversational and generative AI for the health, wellness, senior living, and sleep science sectors. Purpose-built for providers, KOA deploys autonomous AI agents with real-time reasoning, adaptive learning, and actionable intelligence across all communication channels. These human-like agents enable fast, personalized, and context-aware interactions while seamlessly aggregating and analyzing data from all major wearables and contactless sensors. By managing routine tasks and queries, KOA empowers care teams to focus on complex needs and meaningful resident engagement. Stanford Medicine and UCSF independently vet our platform.